http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1437359-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e63a659a420a52a0ac14de119c461b1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
filingDate 1998-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ede5d2fc22dc009841bc1f9b4c499442
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7428d64582c0c640c82a08dad0516dad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0a21ab6e85053b572035bf879d293cf
publicationDate 2005-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1437359-A3
titleOfInvention Novel 3,6-Hemiketals from the Class of 9a-Azalides
abstract The invention relates toncompounds of general formulan(I) characterized in that R 1 nindividually stands for hydroxyl,nL-cladinosyl group of formulan(II) wherein R 2 individuallynstands for hydrogen or ansilyl group; R 3 individuallynstands for hydrogen or togethernwith R 6 stands for an etherngroup; R 4 individually standsnfor hydrogen, (C 1 -C 4 )acylngroup or -COO-(CH 2 ) n -Arngroup, wherein n is 1-7 andnAr individually stands fornunsubstituted or substitutednaryl group with up to 18ncarbon atoms; R 5 individuallynstands for hydrogen, methylngroup or -COO-(CH 2 ) n -Arngroup, wherein n is 1-7 andnAr individually stands fornunsubstituted or substituted arylngroup with up to 18 carbonnatoms; R 6 individually standsnfor a hydroxyl group or togethernwith R 3 stands for an etherngroup; R 7 individually standsnfor hydrogen, (C 1 -C 12 )alkylngroup, silyl group or together with R g and C-11/C-12 carbon atoms stands for a cyclic carbonate, R 8 individually stands for hydrogen,n(C 1 -C 12 )alkyl group, silyl group or together with R 7 and C-11/C-12 carbon atoms stands for a cyclic carbonate; and its pharmaceuticallynacceptable additions salts with inorganic or organic acids, to a process for the preparation thereof and to the use thereof as antibiotics ornas intermediates for the synthesis of other macrolide antibiotics.
priorityDate 1997-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2691464-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0283055-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458399598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974

Total number of triples: 31.